Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Remdesivir”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Testing effectiveness (Phase 2)Looking for participantsNCT06873633
What this trial is testing

Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV

Who this might be right for
Respiratory Syncytial Virus (RSV)
PENTA Foundation 120
Large-scale testing (Phase 3)Study completedNCT04409262
What this trial is testing

Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Hoffmann-La Roche 649
Not applicableNot Yet RecruitingNCT06610643
What this trial is testing

Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immunocompromised Patients

Who this might be right for
COVID-19SARS-CoV-2Immunocompromised
National Taiwan University Hospital 40
Not applicableStudy completedNCT04690920
What this trial is testing

Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins

Who this might be right for
Corona Virus Disease 2019 (COVID-19)
University of Lahore 200
Testing effectiveness (Phase 2)UnknownNCT04647695
What this trial is testing

IFN-beta 1b and Remdesivir for COVID19

Who this might be right for
Covid19
The University of Hong Kong 100
Large-scale testing (Phase 3)Study completedNCT04853901
What this trial is testing

Remdesivir Efficacy In Management Of COVID-19 Patients

Who this might be right for
Covid19
Ain Shams University 77
Not applicableStudy completedNCT05239988
What this trial is testing

Observational Study in COVID-19 Patients Treated With Remdesivir

Who this might be right for
Hospitalization
Fadoi Foundation, Italy 1,004
Large-scale testing (Phase 3)Temporarily pausedNCT04252664
What this trial is testing

A Trial of Remdesivir in Adults With Mild and Moderate COVID-19

Who this might be right for
COVID-19SARS-CoV-2
Capital Medical University 308
Testing effectiveness (Phase 2)Study completedNCT02818582
What this trial is testing

GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen

Who this might be right for
Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 38
Not applicableStudy completedNCT04365725
What this trial is testing

Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections

Who this might be right for
COVID-19
Assistance Publique - Hôpitaux de Paris 84
Not applicableUnknownNCT04728880
What this trial is testing

Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience

Who this might be right for
Pneumonia, Viral
Mansoura University 300
Post-approval studies (Phase 4)UnknownNCT04944082
What this trial is testing

Remdesivir- Ivermectin Combination Therapy in Severe Covid-19

Who this might be right for
Covid19
Assiut University 60
Large-scale testing (Phase 3)Study completedNCT04292899
What this trial is testing

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19
Gilead Sciences 4,891
Large-scale testing (Phase 3)Ended earlyNCT04713176
What this trial is testing

Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients

Who this might be right for
Severe COVID-19
Daewoong Pharmaceutical Co. LTD. 240
Large-scale testing (Phase 3)Looking for participantsNCT07013474
What this trial is testing

Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Who this might be right for
COVID-19 Infection
Pfizer 300
Large-scale testing (Phase 3)Study completedNCT04431453
What this trial is testing

Study of Remdesivir in Participants Below 18 Years Old With COVID-19

Who this might be right for
COVID-19
Gilead Sciences 59
Large-scale testing (Phase 3)Study completedNCT04678739
What this trial is testing

Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial

Who this might be right for
Covid19Covid-19 ARDS
M Abdur Rahim Medical College and Hospital 205
Post-approval studies (Phase 4)Looking for participantsNCT06792214
What this trial is testing

Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial

Who this might be right for
SARS CoV-2 Post-Acute Sequelae
Mount Sinai Hospital, Canada 118
Testing effectiveness (Phase 2)Ended earlyNCT04410354
What this trial is testing

Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19

Who this might be right for
COVID-19
ViralClear Pharmaceuticals, Inc. 44
Post-approval studies (Phase 4)UnknownNCT04738045
What this trial is testing

Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients

Who this might be right for
Covid19
Ahmed Essam 90
Next Page